New research adds to our understanding of the function of the human genome. An international team of researchers has made ...

In vivo perturbations and single-cell RNA-seq reveal cell-type-specific STAT1-IFNg signaling in regulation of trained immunity in tissue-resident immune cells.

Colossal Biosciences, which aims to revive extinct species, has raised an additional $200 million. Critics say de-extinction ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal ...

Achieved in vivo preclinical proof of concept of editing hematopoietic stem cells in non-human primates as a key step toward developing a novel ...

The deal values privately held Truveta at more than $1 billion, it said. Biotechnology company Regeneron pledged to put in ...

HC Wainwright reiterated their buy rating on shares of Precision BioSciences (NASDAQ:DTIL – Free Report) in a research note issued to investors on Friday,Benzinga reports. HC Wainwright currently has ...

BMO Capital Markets upgraded shares of Precision BioSciences (NASDAQ:DTIL – Free Report) from a market perform rating to an outperform rating in a report released on Friday, Marketbeat Ratings reports ...

Researchers have developed a therapy to treat Stargardt disease, the most common form of inherited macular degeneration, ...

The core components of CRISPR-based genome-editing therapies are bacterial proteins called nucleases that can stimulate ...